Skip to content
Stop using now Drug recall · FDA · Published May 1, 2018

AuroMedics Ampicillin/Sulb: Red rubber particles risk in injections

AuroMedics Pharma recalls 3g vials of Ampicillin/Sulbactam injections due to reported red rubber particles. Stop using if you have these specific lots.

🇺🇸 FDA recall #D-0866-2018DrugAuroMedics ›
Take action

Contact the company

Recalling firmAuroMedics Pharma LLC279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
✎ GovInfoNow plain-language explainer

AuroMedics Pharma recalled 3g vials of Ampicillin and Sulbactam injections after reports of red rubber particles. This could cause serious injury if injected. Read more at govinfonow.com/recall/40580-auromedics-ampicillin-sulb-red-rubber-particles-risk-in-injections.

Source Summary by GovInfoNow · govinfonow.com/recall/40580-auromedics-ampicillin-sulb-red-rubber-particles-risk-in-injections · Updated October 7, 2026 · FDA enforcement record: FDA #D-0866-2018

Cite this page

“AuroMedics Ampicillin/Sulb: Red rubber particles risk in injections.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40580-auromedics-ampicillin-sulb-red-rubber-particles-risk-in-injections. Based on FDA recall #D-0866-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0866-2018%22&limit=1).

The FDA announced on May 1, 2018, that AuroMedics Pharma LLC voluntarily recalled Ampicillin and Sulbactam for Injection due to the presence of visible particulate matter. The recall affects 54,720 vials distributed nationwide.

How to tell if you have it

  • Brand: AuroMedics
  • Product: Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial
  • NDC: 55150-117-20
  • Lot codes: AS0317041-A, AS0317035-A
  • Expiration: August 2019

The hazard

The recall was issued after a confirmed customer report of visible particulate matter believed to be red rubber particles from the manufacturing process. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show AuroMedics Pharma LLC has 22 other recalls on record since December 4, 2017. Recent similar recalls include an AuroMedics Fondaparinux Injection recall on September 30, 2022, for subpotent drug risk and an AuroMedics Tranexamic Acid Injection recall on September 26, 2022, for metal particulate hazard. Other recent recalls of similar products include Sun Pharmaceutical DOXOrubin Liposome Injection (May 12, 2026) and American Regent Atropine Sulfate Injection (July 24, 2026).

How to tell if you have this one

Check your vial label for the lot numbers AS0317035-A or AS0317041-A. The product was manufactured for intramuscular or intravenous use and expires August 2019.

  • Brand
    AuroMedics
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Immediately

    Discard the vial if you have the recalled lot numbers AS0317035-A or AS0317041-A.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide in the USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6.5 years after the firm started it.

1. Firm started the recall: May 1, 201812. Published in FDA’s Enforcement Report: May 16, 201823. FDA classified it Class I: Jun 14, 201834. FDA terminated the recall: Nov 6, 2024420182024
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0866-2018 (May 1, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0866-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA